China Universal Asset Management Co., Ltd. Vaxcyte, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 25,827 shares of PCVX stock, worth $946,043. This represents 0.09% of its overall portfolio holdings.
Number of Shares
25,827
Previous 26,428
2.27%
Holding current value
$946,043
Previous $2.16 Million
54.92%
% of portfolio
0.09%
Previous 0.21%
Shares
16 transactions
Others Institutions Holding PCVX
# of Institutions
340Shares Held
136MCall Options Held
348KPut Options Held
250K-
Ra Capital Management, L.P. Boston, MA12.2MShares$446 Million9.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$441 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X011.8MShares$431 Million0.25% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$364 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA6.42MShares$235 Million0.05% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $2.17B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...